L

Lexeo Therapeutics

Gene therapy for cardiac, neurological diseases

Director/Senior Director - Clinical Development

Biology & BiotechUpdated on Nov 11
Full-timeNew York, NY, USA$247.5k - $382k /yr

About the Job

Requirements

  • PhD, PharmD, or MD with a minimum of 6 years of industry experience (8 years for Senior Director), including 5–6 years of progressive clinical development and late-stage trial delivery experience.
  • Proven experience leading late-stage (Phase 2/3 and/or registrational) development for rare disease programs.
  • Demonstrated experience supporting regulatory submission readiness, including BLA filing activities such as clinical deliverables coordination, inspection readiness support, and cross-functional alignment.
  • Thorough knowledge of development program management from IND through NDA/BLA, including audit and inspection readiness.
  • Experience partnering with Clinical Operations and CROs/vendors to deliver high-quality data and documentation, including milestone management, budget awareness, and reporting/CSR support.
  • Advanced working knowledge of relevant guidelines and regulations, including ICH, GCP, and FDA requirements.
  • Ability to operate effectively in a fast-paced environment with shifting priorities and timelines.
  • Excellent communication skills and demonstrated ability to influence across multiple functions and levels, internally and externally.

Responsibilities

  • Provide clinical development leadership for assigned programs, including late-stage (Phase 2/3 and/or registrational) studies in rare disease and gene therapy.
  • Partner with Regulatory, CMC, Quality, Biometrics, Medical Writing, and Clinical Operations to shape an integrated development plan aligned with program objectives and BLA strategy.
  • Lead clinical strategy and oversee protocol development, endpoint selection, eligibility criteria, safety monitoring approach, and clinical rationale to support health authority interactions.
  • Serve as a clinical leader for investigator and external expert engagement, including KOL interactions, advisory boards as applicable, and site relationships to support enrollment and high-quality study conduct.
  • Drive cross-functional issue resolution and risk management for study execution; ensure decisions are documented and aligned with quality standards and inspection readiness.
  • Contribute to BLA readiness by ensuring clinical deliverables and timelines are aligned across functions, including CSR strategy, data review readiness, and clinical module inputs.
  • Lead and/or mentor team members through matrix leadership; support a culture of accountability, collaboration, and scientific rigor.

About the Company

Lexeo Therapeutics

Gene therapy for cardiac, neurological diseases

Lexeo Therapeutics develops gene therapies for genetic cardiac and neurological diseases. It advances therapies by conducting research, running clinical trials, and pursuing commercialization through partnerships and grants. It differentiates itself with a strong academic foundation and collaboration with Weill Cornell’s Department of Genetic Medicine, while focusing on end-to-end development from discovery to trials. Its goal is to bring genetic medicines to patients with unmet medical needs through partnerships, clinical trials, and eventual market availability.

Company size
51-200
Company stage
IPO
Headquarters
New York City, New York
Founded
2018

Recently Posted Jobs

Explore more opportunities at Lexeo Therapeutics

See more jobs